Clinical Research/R&D

  • Your Selections:

Refine Results

date

Tags

Pfizer-BioNTech To File With FDA For Emergency Authorization Of Coronavirus Vaccine; Oxford Vaccine Results Expected By Year’s End; Wealthy Nations Urged To Waive IP Rights On, Create Humanitarian Stockpile Of Vaccines

CNBC: Pfizer and BioNTech to request emergency authorization from FDA for Covid vaccine “Pfizer and BioNTech will apply Friday for an emergency use authorization from the Food and Drug Administration for their coronavirus vaccine. If Pfizer’s application is approved, the vaccine will likely be limited and rolled out in phases,…

Blog Posts, Releases Address Topics Related To COVID-19, Including Role Of Government In Public Health; Funding COVID-19 Recovery; Data Protection, Privacy Amid Pandemic

CATO Institute: The COVID Vaccine Trials & the Role of Government in Public Health Terence Kealey, adjunct scholar at the CATO Institute and professor of clinical biochemistry at the University of Buckingham (11/18). Center for Global Development: Realizing Savings from Better Procurement Today to Build Resilient Health Systems for Tomorrow…

Editorial, Opinion Pieces Address Topics Related COVID-19, Including Vaccine Distribution Challenges; Lessons From HIV Response; Pandemic’s Disruption To Polio, Measles Vaccination Campaigns

Devex: Opinion: How AI can push for equitable access to COVID-19 vaccines Jayasree Iyer, executive director, and Thomas Collin-Lefebvre, researcher to the executive director, both at the Access to Medicine Foundation (11/18). Devex: Opinion: Why exciting results from vaccine research are just the beginning of efforts to end COVID-19 Mitchell…

School-Aged Children Can Serve As Malaria Superspreaders, Research Shows

Devex: Children as superspreaders of malaria “New research from Uganda found that asymptomatic, school-aged children can serve as superspreaders of malaria. These findings suggest that efforts to eliminate the disease from countries might be harder than previously thought. The findings, which were presented at the annual meeting of the American…

Opinion Pieces Discuss Issues Related To COVID-19 Vaccine Development, Distribution, Public Confidence, Access

The Conversation: Buying and distributing a COVID-19 vaccine will involve hard ethical and practical choices Barbara Allen, senior lecturer in public management, and Michael Macaulay, professor of public administration, both at Te Herenga Waka — Victoria University of Wellington (11/17). The Conversation: Virus evolution could undermine a COVID-19 vaccine –…

New Results Show 95% Efficacy For Pfizer-BioNTech Coronavirus Vaccine, No Serious Side Effects; Developing Nations To Argue For Patent Suspensions Of Vaccines At WTO Meeting

New York Times: New Pfizer Results: Coronavirus Vaccine Is Safe and 95% Effective “The drug maker Pfizer said on Wednesday that its coronavirus vaccine was 95 percent effective and had no serious side effects — the first set of complete results from a late-stage vaccine trial as Covid-19 cases skyrocket…

WHO Welcomes Coronavirus Vaccine Research Results, Urges Continued Data Collection, Cautions Over Challenges To Distribution; Media Outlets Report On Other Vaccine-Related News

Reuters: World should not be complacent after COVID-19 vaccine news: WHO “The World Health Organization (WHO) welcomed Moderna reporting on Monday that its experimental vaccine showed 94.5% efficacy but said that ‘many questions’ remained and it was no time for complacency…” (Nebehay/Farge, 11/16). Reuters: WHO sees limited COVID-19 vaccine doses…

Moderna Announces Coronavirus Vaccine Efficacy Of Nearly 95% In Preliminary Clinical Trial Results; Media Outlets Report On Other Vaccine Research, Issues

Washington Post: Moderna’s coronavirus vaccine found to be nearly 95 percent effective in a preliminary analysis “Biotechnology firm Moderna announced Monday that a preliminary analysis shows its experimental coronavirus vaccine is nearly 95 percent effective at preventing illness, including severe cases — a striking initial result that leaves the United…

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.